We therefore evaluated the relationship between HCC recurrence after LDLT and proliferation of α-SMA-positive CAFs, as well as the correlation between eligibility criteria and α-SMA-positive CAFs. The gene discussed is ACTA1; the disease is hepatocellular carcinoma.